Timing of bevacizumab administration after biopsy for unresectable newly diagnosed glioblastoma
Article in Surgical Neurology International (December 2022)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective Study
Article in World Neurosurgery (December 2021)
Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma
Article in Journal of Neuro-Oncology (July 2021)